February 9, 2021 | Compliance An Analysis Of MHRA’s Latest Annual GMP Inspection Deficiencies Report Are you aware of recent changes from EMA pertaining to manufacturers of chemically synthesized drugs and biological products? Barbara Unger Principal Consultant 10 Minute Read
April 20, 2020 | Industry Updates Resuming Business Operations Following the COVID-19 Pandemic: Part One Stephanie Colotti Senior Partner, Validant 8 Minute Read